K

KNSA

KNSA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
KNSA Live QuoteReal-time
$93.53
+$13.83(+17.36%)1M
Day Range$93.03 – $96.18
Open$95.00
Previous Close$95.05
Volume427.5K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$7.35B
P/E Ratio (TTM)70.9
Forward P/E59.9
EPS (TTM)$1.32
Price to Book10.5
Dividend Yield0.65%
Beta (Volatility)0.08
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $93.53 (91%)
Low: $37.02High: $99.31
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$111.57-25.6% upside

Insider Buys

0

$0

Insider Sales

76

$176.68M

Total Volume

$176.68M

76 transactions

Net Activity

$176.68M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
P
1

Patel Sanj K

COB, CEO

0 buys11 sells

$95.93M total

T
2

Tessari Eben

COO

0 buys20 sells

$18.26M total

P
3

Paolini John F.

CHIEF MEDICAL OFFICER

0 buys6 sells

$17.89M total

M
4

Moat Ross

COO

0 buys8 sells

$13.66M total

R
5

Ragosa Mark

CFO

0 buys14 sells

$13.32M total

Trading History
KNSA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 4, 2026

2 weeks ago

Patel Sanj K

COB, CEO

CEO
Sell151.3K$94.71$14.33M

Nov 2, 2026

2 weeks ago

Ragosa Mark

CFO

CFO
Sell36.8K$92.16$3.39M

Oct 30, 2026

3 weeks ago

Paolini John F.

CHIEF MEDICAL OFFICER

C-Level
Sell96.0K$93.09$8.94M

Oct 30, 2026

3 weeks ago

Moat Ross

COO

COO
Sell103.6K$92.93$9.63M

Oct 30, 2026

3 weeks ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell36.3K$94.43$3.42M

Oct 30, 2026

3 weeks ago

Patel Sanj K

COB, CEO

CEO
Sell402.5K$92.92$37.40M

Jul 29, 2026

3 months ago

Cole G Bradley

Dir

Director
Sell3.7K$81.43$299K

May 1, 2026

6 months ago

Paolini John F.

CHIEF MEDICAL OFFICER

C-Level
Sell58.4K$53.71$3.14M

May 1, 2026

6 months ago

Patel Sanj K

COB, CEO

CEO
Sell48.6K$54.02$2.62M

Apr 28, 2026

6 months ago

Patel Sanj K

COB, CEO

CEO
Sell508.3K$51.96$26.42M

Apr 28, 2026

6 months ago

Quart Barry D

Dir

Director
Sell13.1K$50.10$656K

Apr 9, 2026

7 months ago

Moat Ross

COO

COO
Sell1.7K$46.69$80K

Apr 9, 2026

7 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell6.6K$46.69$309K

Apr 6, 2026

7 months ago

Moat Ross

COO

COO
Sell2.4K$48.58$115K

Apr 6, 2026

7 months ago

Quart Barry D

Dir

Director
Sell6.9K$50.00$345K

Apr 6, 2026

7 months ago

Patel Sanj K

COB, CEO

CEO
Sell7.3K$50.01$364K

Mar 2, 2026

8 months ago

Paolini John F.

CHIEF MEDICAL OFFICER

C-Level
Sell40.0K$44.82$1.79M

Feb 10, 2026

9 months ago

Quart Barry D

Dir

Director
Sell2.8K$45.00$126K

Feb 9, 2026

9 months ago

Ragosa Mark

CFO

CFO
Sell17.8K$43.28$772K

Feb 2, 2026

9 months ago

Quart Barry D

Dir

Director
Sell16.0K$45.22$722K

Jan 8, 2026

10 months ago

Ragosa Mark

CFO

CFO
Sell12.0K$41.89$503K

Dec 15, 2025

11 months ago

Tessari Eben

COO

COO
Sell12.0K$41.56$501K

Dec 15, 2025

11 months ago

Quart Barry D

Dir

Director
Sell20.1K$41.51$836K

Dec 8, 2025

11 months ago

Ragosa Mark

CFO

CFO
Sell42.8K$41.49$1.78M

Nov 26, 2025

11 months ago

Tessari Eben

COO

COO
Sell200$42.89$9K

Nov 17, 2025

12 months ago

Tessari Eben

COO

COO
Sell12.5K$41.24$514K

Nov 12, 2025

12 months ago

Ragosa Mark

CFO

CFO
Sell19.9K$40.94$815K

Oct 31, 2025

12 months ago

Paolini John F.

CHIEF MEDICAL OFFICER

C-Level
Sell82.5K$37.14$3.07M

Oct 28, 2025

12 months ago

Ragosa Mark

CFO

CFO
Sell100$41.00$4K

Oct 20, 2025

13 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell50.5K$38.87$1.96M

Oct 20, 2025

13 months ago

Patel Sanj K

COB, CEO

CEO
Sell258.0K$38.86$10.02M

Oct 14, 2025

13 months ago

Tessari Eben

COO

COO
Sell12.4K$37.67$466K

Sep 29, 2025

13 months ago

Tessari Eben

COO

COO
Sell42.0K$38.33$1.61M

Sep 15, 2025

14 months ago

Tessari Eben

COO

COO
Sell16.4K$36.46$598K

Sep 4, 2025

14 months ago

Tessari Eben

COO

COO
Sell98.7K$35.54$3.51M

Sep 4, 2025

14 months ago

Moat Ross

CHIEF CORP., COMM. OFFICER

C-Level
Sell3.5K$35.31$124K

Sep 3, 2025

14 months ago

Tessari Eben

COO

COO
Sell15.1K$35.50$536K

Sep 3, 2025

14 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell11.0K$34.84$383K

Aug 18, 2025

15 months ago

Tessari Eben

COO

COO
Sell16.2K$33.77$547K

Aug 12, 2025

15 months ago

Malley Thomas

Dir

Director
Sell177.8K$32.96$5.86M

Aug 6, 2025

15 months ago

Paolini John F.

CHIEF MEDICAL OFFICER

C-Level
Sell29.3K$32.55$955K

Aug 5, 2025

15 months ago

Tessari Eben

COO

COO
Sell138.6K$33.20$4.60M

Aug 4, 2025

15 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell17.0K$32.35$550K

Aug 4, 2025

15 months ago

Ragosa Mark

CFO

CFO
Sell18.9K$32.89$621K

Jul 14, 2025

16 months ago

Tessari Eben

COO

COO
Sell18.9K$28.72$543K

Jun 16, 2025

17 months ago

Tessari Eben

COO

COO
Sell17.3K$28.28$489K

Jun 9, 2025

17 months ago

Tessari Eben

COO

COO
Sell70.9K$30.48$2.16M

Jun 9, 2025

17 months ago

Quart Barry D

Dir

Director
Sell27.4K$30.35$833K

Jun 3, 2025

17 months ago

Moat Ross

CHIEF COMMERCIAL OFFICER

C-Level
Sell27.6K$29.02$801K

Jun 3, 2025

17 months ago

Ragosa Mark

CFO

CFO
Sell18.3K$28.80$527K

Jun 3, 2025

17 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell15.2K$28.75$437K

May 23, 2025

18 months ago

Patel Sanj K

COB, CEO

CEO
Sell86.3K$27.24$2.35M

May 20, 2025

18 months ago

Patel Sanj K

COB, CEO

CEO
Sell2.3K$27.02$63K

May 19, 2025

18 months ago

Tessari Eben

COO

COO
Sell12.0K$26.41$317K

May 13, 2025

18 months ago

Patel Sanj K

COB, CEO

CEO
Sell2.9K$27.03$78K

May 7, 2025

18 months ago

Paolini John F.

CHIEF MEDICAL OFFICER

C-Level
Sell200$27.00$5K

May 7, 2025

18 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell17.6K$26.69$471K

May 7, 2025

18 months ago

Patel Sanj K

COB, CEO

CEO
Sell8.1K$27.04$219K

May 2, 2025

18 months ago

Moat Ross

CHIEF COMMERCIAL OFFICER

C-Level
Sell10.1K$28.00$283K

Apr 29, 2025

19 months ago

Ragosa Mark

CFO

CFO
Sell88.4K$26.56$2.35M

Apr 29, 2025

19 months ago

Moat Ross

CHIEF COMMERCIAL OFFICER

C-Level
Sell87.3K$25.96$2.27M

Apr 21, 2025

19 months ago

Moat Ross

CHIEF COMMERCIAL OFFICER

C-Level
Sell18.3K$20.29$370K

Apr 14, 2025

19 months ago

Tessari Eben

COO

COO
Sell12.0K$20.48$246K

Mar 20, 2025

20 months ago

Ragosa Mark

CFO

CFO
Sell15.9K$23.11$368K

Mar 17, 2025

20 months ago

Ragosa Mark

CFO

CFO
Sell20.3K$23.10$470K

Mar 12, 2025

20 months ago

Ragosa Mark

CFO

CFO
Sell36.4K$22.25$809K

Mar 12, 2025

20 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell9.1K$22.45$203K

Mar 10, 2025

20 months ago

Tessari Eben

COO

COO
Sell12.4K$21.06$261K

Feb 10, 2025

21 months ago

Tessari Eben

COO

COO
Sell14.0K$19.57$274K

Jan 13, 2025

22 months ago

Tessari Eben

COO

COO
Sell14.0K$18.24$255K

Dec 16, 2024

23 months ago

Tessari Eben

COO

COO
Sell23.0K$20.44$470K

Dec 6, 2024

23 months ago

Ragosa Mark

CFO

CFO
Sell27.8K$21.34$594K

Dec 3, 2024

23 months ago

Ragosa Mark

CFO

CFO
Sell15.1K$21.37$323K

Nov 27, 2024

24 months ago

Megna Michael R

CHIEF ACCOUNTING OFFICER

C-Level
Sell8.6K$22.45$194K

Nov 18, 2024

24 months ago

Tessari Eben

COO

COO
Sell17.0K$21.04$358K

Nov 6, 2024

24 months ago

Patel Sanj K

COB, CEO

CEO
Sell89.6K$23.00$2.06M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
KNSA Buy Conviction0%
Industry Rank#25 of 569
Volume Contribution1.1%
Total Industry Activity$16.53B

KNSA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. KNSA ranks #25 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for KNSA

Over the last 90 days, corporate insiders at KNSA (KNSA) engaged in a total of 76 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 76 were sales. The total volume of insider trading reached $176.68M.

The net insider activity for KNSA shows a net selling bias of $176.68M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Patel Sanj K (COB, CEO), who traded 402.5K shares valued at $37.40M on Oct 30, 2026.

Live Market News & Developments
Aggregated real-time headlines for KNSA (KNSA)
6 updates

Kiniksa Pharmaceuticals, Ltd. (KNSA) stock price, news, quote and history

Yahoo Finance UK6h ago

TD Cowen highlights catalysts for a 2027 Best Idea stock

Investing.com14h ago

TD Cowen Lifts Kiniksa Target to $115, Touts Wholly Owned Drug as 2027 EPS Lever

BigGo Finance13h ago

KNSA - Kiniksa Pharmaceuticals International Plc Stock Price and Quote

Finviz177d ago

Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment (NASDAQ:KNSA)

Seeking Alpha49d ago

TD Cowen Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock

MarketBeat2d ago

FAQs About KNSA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for KNSA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for KNSA is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 76 sales by company executives over the last 90 days.

The CEO Conviction Index for KNSA is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.